FDA 483 - JFC International, Inc - February 20, 2026

From February 19 to February 20, 2026, the Food and Drug Administration (FDA) inspected the JFC International, Inc. warehouse facility in Coppell, Texas. The inspection identified critical safety violations regarding the handling of imported refrigerated fresh fish, including products using Reduced Oxygen Packaging (ROP). The primary issue found was the company"s failure to follow its safety protocols, known as a HACCP plan, when temperature deviations occurred during transport. Specifically, the firm accepted several shipments of seafood—including Mackerel, Yellowtail, and Tuna—despite temperature monitoring devices showing they had been exposed to unsafe heat levels for extended periods, in one instance for over 24 hours. These temperature excursions pose a significant risk for the growth of dangerous bacteria like Clostridium botulinum and the formation of histamines. Furthermore, the inspection noted that staff frequently marked failing shipments as passing or conditionally accepted them without conducting necessary hazard evaluations. The company also failed to follow its own procedures to stop using suppliers that consistently failed to monitor temperatures correctly. These findings were issued under the Federal Food, Drug, and Cosmetic Act to ensure the facility maintains sanitary conditions and prevents the distribution of injurious food products. JFC International is required to respond to these observations by detailing the corrective actions they have implemented or plan to take to bring their operations into compliance with safety regulations.